Cargando…
Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma
BACKGROUND: Genome-wide association study (GWAS) is a powerful tool to identify novel pharmacogenetic single nucleotide polymorphisms (SNPs). Leukotriene receptor antagonists (LTRAs) are a major class of asthma medications, and genetic factors contribute to variable responses to these drugs. We used...
Autores principales: | Dahlin, Amber, Litonjua, Augusto, Lima, John J., Tamari, Mayumi, Kubo, Michiaki, Irvin, Charles G., Peters, Stephen P., Tantisira, Kelan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470685/ https://www.ncbi.nlm.nih.gov/pubmed/26083242 http://dx.doi.org/10.1371/journal.pone.0129385 |
Ejemplares similares
-
The phosphatidylinositide 3-kinase (PI3K) signaling pathway is a determinant of zileuton response in adults with asthma
por: Dahlin, Amber, et al.
Publicado: (2018) -
Genome-wide association study of leukotriene modifier response in asthma
por: Dahlin, A, et al.
Publicado: (2016) -
Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiers
por: Xu, Mousheng, et al.
Publicado: (2011) -
Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes
por: Choi, Jihoon, et al.
Publicado: (2018) -
CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids
por: Dahlin, Amber, et al.
Publicado: (2015)